Santhera Pharmaceuticals Holding AG

Fr 14.92As of Sun 8 Nov 2026, 12:00 UTC
SWX:SANNHealthcare
Country Switzerland
PE (Fwd) •••
TSR 10Y CAGR (28.58%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (0.41)
PE TTM —
TSR TTM 46.27%
Mkt cap Fr 228.4M
ROIC (8.83%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
Fr 18
23.23%
(1.48%)
Hold 4|2|4|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per shareFr
0.22
0.23
0.24
0.25
25.96%
33.06%
33.18%
26.05%
RevenueFr M
11.71
11.48
11.57
11.42
4.46%
2.15%
(2.64%)
(3.38%)
Peers (US$280.1M)
Cap (US$)
PE
462.4M
—
221.7M
—
161.1M
—
279.8M
—
Capital
TTM
5Y
10Y
Leveragex
2.898
0.011
0.011
EBIT/Intx
2.425
1.985
1.917
Own earn%
(30.39)
(3.05)
2.11
Sh yield%
28.29
42.18
43.11
Owners
Insiders/Inst%
7.17
34.46
Short interest%
2.55
SBC / revenue%
2.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
22–29
$1 testx
−0.1
Incr. ROIC%
17